Published

What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Cochrane Clinical Answers
Date: 2025-01-12
Source: OpenAlex
DOI: 10.1002/cca.4512
PubMed: Unavailable

Authors

Amin Sharifan

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?2025-01-12

Related papers

PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29